Stocks
Elutia Inc.ELUT
NASDAQHealthcareBiotechnology$0.84
Price as of · delayed, not real-time
A commercial-stage medical technology company developing bioengineered implantable products for surgical procedures, with a focus on reducing infection and improving patient outcomes. Its lead products include antimicrobial and regenerative tissue matrices used in cardiac, vascular, and soft tissue repair. Investors track the company for its differentiated technology platform and its potential to capture share in the surgical reconstruction market.
52W Range: $0.50-$1.39
Congressional Interest in Elutia Inc. (ELUT)
No congressional trades have been disclosed for Elutia Inc. (ELUT) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ELUT?
No congressional trades found for this stock.